Program News
News and stories about members of the UNC Lineberger Breast Cancer Research Program
-
Researchers develop AI model to improve tumor removal accuracy during breast cancer surgery
Kristalyn Gallagher, DO, and colleagues have developed an AI model that can predict whether or not cancerous tissue has been fully removed from the body during breast cancer surgery.
-
UNC Lineberger research featured at American Society of Clinical Oncology annual meeting
UNC Lineberger members and trainees will present cancer research findings at the 2023 American Society of Clinical Oncology annual meeting in Chicago, June 2-6.
-
Top UNC cancer researcher receives 2023 Oliver Max Gardner Award
H. Shelton “Shelley” Earp, MD, director of the UNC Lineberger Comprehensive Cancer Center and UNC Cancer Care, received the prestigious Oliver Max Gardner Award.
-
Spanheimer earns Society of Surgical Oncology Young Investigator Award
UNC Lineberger’s Philip Spanheimer, MD, was presented with a Young Investigator Award at the Society of Surgical Oncology annual meeting.
-
Perou elected as fellow of the American Association for Cancer Research Academy
The AACR has elected Charles Perou, PhD, as a fellow to the AACR Academy. Members of this year’s class will be formally recognized at the AACR’s annual meeting.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
Office of Graduate Education recognizes four Lineberger members with mentorship awards
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
-
Race and geography linked to different risks of breast cancer treatment delays
A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.
-
Study identifies molecular differences between primary breast cancer and its metastases
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
-
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
-
Perou presents AACR Distinguished Lectureship in Breast Cancer Research
Charles Perou, PhD, presented the 2022 AACR Distinguished Lectureship in Breast Cancer Research at the 45th San Antonio Breast Cancer Symposium.
-
Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores
Yara Abdou, MD, lead author of the study, presented findings at the San Antonio Breast Cancer Symposium.
-
UNC Lineberger researchers present findings at San Antonio Breast Cancer Symposium
UNC Lineberger researchers and colleagues will be presenting the latest findings from basic, translational and clinical studies at the 45th annual San Antonio Breast Cancer Symposium.
-
UNC Lineberger faculty recognized as world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
-
Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life
Researchers developed three different computer models to predict how a hypothetical set of patients with specific types of metastatic breast cancer would respond to different sequences and types of chemotherapy.